Does NSE’s price capping on SME IPOs mean no multibagger returns on Day 1?

July 5, 2024

As SME IPOs gain traction among investors, regulators are moving to formalise the market with stricter controls. The NSE recently imposed a cap on SME issue listing prices at 90%, independent of grey market trends. This impacted Nephro Care, which despite a 300% pre-listing GMP, debuted at only a 90% premium due to the exchange’s price cap.

More To Explore

New senior citizens policy in the works after 25 years

India is developing a new senior citizen policy and amending the Maintenance and Welfare of Parents and Senior Citizens Act 2007 to address the needs

November 15, 2024

The gamification of India’s investment landscape decoded

India’s retail investment boom is driven by tech and gamification but raises risks. Regulatory reforms on transparency, investor education, and gamification practices are essential to

November 15, 2024

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003